04.02.2025

Biotechnology company Medix Biochemica succeeds in a strategic acquisition with Luther's support

The Health Care team of Luther Rechtsanwaltsgesellschaft has advised Oy Medix Biochemica Ab, a portfolio company of the Finnish long-term-oriented investment company DevCo Partners, on the acquisition of CANDOR Bioscience GmbH to expand its portfolio in the field of critical raw materials for the in-vitro diagnostics industry.

Background

Since January 2025, CANDOR Bioscience GmbH, an internationally active biotechnology company focused on the development, production and distribution of high-quality solutions for immunoassays, has been part of the Finnish Oy Medix Biochemica Ab Group. With the acquisition of CANDOR Bioscience GmbH, Oy Medix Biochemica Ab has continued to strategically expand its market-leading range of critical raw materials for the in vitro diagnostics industry.

Luther's experienced Health Care team led by transaction specialists Dr. Oliver Kairies, Dr. Daniel Schubmann and Dr. Karina Wojtowicz handled the transaction for the Medix Biochemica Group, negotiated the respective transaction agreements with the various seller parties and provided comprehensive advice on the implementation of the transaction.

About Oy Medix Biochemica Ab:

Oy Medix Biochemica Ab, a portfolio company of the Finnish long-term oriented investment company DevCo Partners, is a market-leading supplier of raw materials for in-vitro diagnostics worldwide. The company focuses on the production and supply of high-quality antibodies, antigens and other critical IVD raw materials for the manufacture of diagnostic tests and supporting materials. DevCo Partners is a long-term active owner and development partner dedicated to building and developing world-leading companies in selected niche markets. DevCo was founded in 2014 and, in addition to Oy Medix Biochemica Ab, owns, inter alia, another leading global niche company, Vexve Armatury Group, which Luther had already advised on its entry into the German market in 2020.

For the Oy Medix Biochemica Ab:

Luther, Corporate/M&A: Dr Oliver Kairies (Partner), Dr Daniel Schubmann (Counsel), Dr Karina Wojtowicz (Senior Associate), Timo Reckert (Associate), Vivien Insa Seifert (Associate)

Luther, Medical Law: Dr Hendrik Bernd Sehy (Counsel), Frances Wolf (Senior Associate)

Luther, Construction and Real Estate: Dr Thomas Gohrke (Partner)

Luther, Employment: Dr Eva Rütz, LL.M. (Partner), Lisa Kraayvanger (Senior Associate)

Author
Dr Oliver Kairies

Dr Oliver Kairies
Partner
Hanover
oliver.kairies@luther-lawfirm.com
+49 511 5458 17643